SLC1A2 Gene

HGNC Family Solute carriers (SLC)
Name solute carrier family 1 (glial high affinity glutamate transporter), member 2
Description This gene encodes a member of a family of solute transporter proteins. The membrane-bound protein is the principal transporter that clears the excitatory neurotransmitter glutamate from the extracellular space at synapses in the central nervous system. Glutamate clearance is necessary for proper synaptic activation and to prevent neuronal damage from excessive activation of glutamate receptors. Improper regulation of this gene is thought to be associated with several neurological disorders. Alternatively spliced transcript variants of this gene have been identified. [provided by RefSeq, Jun 2017]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSLC1A2 (also known as EAAT2 or GLT‐1) is the principal high‐affinity, Na⁺‐dependent glutamate transporter predominantly expressed in astrocytes that mediates the rapid clearance of extracellular glutamate from synaptic and extrasynaptic regions. This function is critical to maintaining glutamatergic homeostasis and preventing excitotoxic neuronal injury. Studies in human brain microvessels and cortical biopsies have identified SLC1A2 as one of the major solute carrier proteins, while its strong contribution to up to 90% of total glutamate uptake has been confirmed in both physiological and pathological contexts—including neurodegenerative and demyelinating conditions."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "10"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nRegulation of SLC1A2 occurs at multiple levels. Transcriptional events—mediated by signaling pathways such as those involving NF‐κB, epidermal growth factor, and modulators like β‐lactam antibiotics (e.g., ceftriaxone)—can enhance its expression, whereas inflammatory mediators (for example, TNFα) and viral proteins (such as HIV‐1 gp120) may downregulate its transcription or promote its endocytosis. In addition, genetic studies have identified de novo mutations in SLC1A2 that cause epileptic encephalopathies, underscoring its importance in maintaining neuronal excitability."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "11", "end_ref": "20"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its fundamental role in glutamate clearance, the structural organization and post‐transcriptional modulation of SLC1A2 have profound implications for its activity. Evidence indicates that SLC1A2 assembles as a trimer and undergoes alternative splicing events—giving rise to variants such as EAAT2b—that may differentially contribute to synaptic as well as extrasynaptic glutamate uptake. Abnormal expression or dysfunction of SLC1A2 is implicated in multiple neurological and psychiatric disorders including amyotrophic lateral sclerosis, schizophrenia, and alterations in presynaptic glutamate dynamics. Moreover, emerging data highlight its involvement in non‐classical settings such as in retinal photoreceptors and even in the regulation of behaviors like smoking."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "21", "end_ref": "30"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nModulation of SLC1A2 function has attracted considerable therapeutic interest. Pharmacological agents such as riluzole have been shown to enhance its expression via stress‐response pathways (e.g., HSF1 activation), and gene fusion events—in cancers like gastric carcinoma—further underscore the functional versatility of SLC1A2 in metabolic rewiring. In addition, altered glutamate transporter ratios in peripheral tissues, such as pancreatic islets, illustrate its broader role in protecting cells from excitotoxic insults. Genetic polymorphisms and post‐translational modifications, including phosphorylation and ubiquitination mediated by regulatory proteins like PIKfyve, further fine‐tune its localization and activity."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "31", "end_ref": "38"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFinally, recent investigations have extended the significance of SLC1A2 regulation to the aging brain and its epigenetic control. Altered promoter methylation and mislocalization from lipid raft microdomains—as observed in Alzheimer’s disease—coupled with developmental regulation in vulnerable regions such as the periventricular white matter, suggest that precise control of SLC1A2 expression is vital for both cognitive preservation and the prevention of excitotoxic injury. These studies, along with evidence of glutamatergic dysregulation in mood disorders, underscore that maintaining SLC1A2 functionality is pivotal to cell survival under both physiological aging and disease conditions."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "39", "end_ref": "43"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Ramzi Shawahna, Yasuo Uchida, Xavier Declèves, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pharm (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/mp200129p"}], "href": "https://doi.org/10.1021/mp200129p"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21707071"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21707071"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Keetae Kim, Seok-Geun Lee, Timothy P Kegelman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.22609"}], "href": "https://doi.org/10.1002/jcp.22609"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21792905"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21792905"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Shannon R Hinson, Shanu F Roemer, Claudia F Lucchinetti, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20081241"}], "href": "https://doi.org/10.1084/jem.20081241"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18838545"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18838545"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Seok-Geun Lee, Zhao-Zhong Su, Luni Emdad, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M707697200"}], "href": "https://doi.org/10.1074/jbc.M707697200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18326497"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18326497"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Edward Pajarillo, Asha Rizor, Jayden Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropharmacology (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neuropharm.2019.03.002"}], "href": "https://doi.org/10.1016/j.neuropharm.2019.03.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30851309"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30851309"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Unknown Authors "}, {"type": "b", "children": [{"type": "t", "text": "De Novo Mutations in SLC1A2 and CACNA1A Are Important Causes of Epileptic Encephalopathies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajhg.2016.06.003"}], "href": "https://doi.org/10.1016/j.ajhg.2016.06.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27476654"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27476654"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Raquel Sitcheran, Pankaj Gupta, Paul B Fisher, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Positive and negative regulation of EAAT2 by NF-kappaB: a role for N-myc in TNFalpha-controlled repression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO J (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.emboj.7600555"}], "href": "https://doi.org/10.1038/sj.emboj.7600555"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15660126"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15660126"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Zhuying Wang, Olga Pekarskaya, Meryem Bencheikh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Virology (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0042-6822(03)00181-8"}], "href": "https://doi.org/10.1016/s0042-6822(03"}, {"type": "t", "text": "00181-8) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12890621"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12890621"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Zao-zhong Su, Magdalena Leszczyniecka, Dong-chul Kang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Insights into glutamate transport regulation in human astrocytes: cloning of the promoter for excitatory amino acid transporter 2 (EAAT2)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0136555100"}], "href": "https://doi.org/10.1073/pnas.0136555100"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12578975"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12578975"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Heather A Scott, Florian M Gebhardt, Ann D Mitrovic, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Glutamate transporter variants reduce glutamate uptake in Alzheimer's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurobiol Aging (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neurobiolaging.2010.03.008"}], "href": "https://doi.org/10.1016/j.neurobiolaging.2010.03.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20416976"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20416976"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Bruna De Felice, Marco Guida, Maurizio Guida, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2012.07.058"}], "href": "https://doi.org/10.1016/j.gene.2012.07.058"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22903028"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22903028"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Nicholas J Maragakis, Margaret Dykes-Hoberg, Jeffrey D Rothstein "}, {"type": "b", "children": [{"type": "t", "text": "Altered expression of the glutamate transporter EAAT2b in neurological disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Neurol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ana.20003"}], "href": "https://doi.org/10.1002/ana.20003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15048885"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15048885"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Ainara Vallejo-Illarramendi, María Domercq, Fernando Pérez-Cerdá, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased expression and function of glutamate transporters in multiple sclerosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurobiol Dis (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.nbd.2005.06.017"}], "href": "https://doi.org/10.1016/j.nbd.2005.06.017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16061389"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16061389"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "William Boston-Howes, Stuart L Gibb, Eric O Williams, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Caspase-3 cleaves and inactivates the glutamate transporter EAAT2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M600653200"}], "href": "https://doi.org/10.1074/jbc.M600653200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16567804"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16567804"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Jacqueline M Vink, August B Smit, Eco J C de Geus, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genome-wide association study of smoking initiation and current smoking."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajhg.2009.02.001"}], "href": "https://doi.org/10.1016/j.ajhg.2009.02.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19268276"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19268276"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Carlos Matute, Marcello Melone, Ainara Vallejo-Illarramendi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased expression of the astrocytic glutamate transporter GLT-1 in the prefrontal cortex of schizophrenics."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Glia (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/glia.20119"}], "href": "https://doi.org/10.1002/glia.20119"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15494981"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15494981"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Sandra Gendreau, Stephan Voswinkel, Delany Torres-Salazar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A trimeric quaternary structure is conserved in bacterial and human glutamate transporters."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M408038200"}], "href": "https://doi.org/10.1074/jbc.M408038200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15265858"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15265858"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Hae Kyung Lee, Susan Finniss, Simona Cazacu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mesenchymal stem cells deliver exogenous miRNAs to neural cells and induce their differentiation and glutamate transporter expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Stem Cells Dev (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/scd.2014.0146"}], "href": "https://doi.org/10.1089/scd.2014.0146"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25036385"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25036385"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Sandra Thier, Delia Lorenz, Michael Nothnagel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polymorphisms in the glial glutamate transporter SLC1A2 are associated with essential tremor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurology (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/WNL.0b013e31825fdeed"}], "href": "https://doi.org/10.1212/WNL.0b013e31825fdeed"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22764253"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22764253"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Theresa S Rimmele, Paul A Rosenberg "}, {"type": "b", "children": [{"type": "t", "text": "GLT-1: The elusive presynaptic glutamate transporter."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurochem Int (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neuint.2016.04.010"}], "href": "https://doi.org/10.1016/j.neuint.2016.04.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27129805"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27129805"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Seok-Geun Lee, Keetae Kim, Timothy P Kegelman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Oncogene AEG-1 promotes glioma-induced neurodegeneration by increasing glutamate excitotoxicity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-11-0782"}], "href": "https://doi.org/10.1158/0008-5472.CAN-11-0782"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21852380"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21852380"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "T L Lauriat, L A McInnes "}, {"type": "b", "children": [{"type": "t", "text": "EAAT2 regulation and splicing: relevance to psychiatric and neurological disorders."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Psychiatry (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.mp.4002065"}], "href": "https://doi.org/10.1038/sj.mp.4002065"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17684493"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17684493"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Thomas Rauen, Michael Wiessner, Robert Sullivan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A new GLT1 splice variant: cloning and immunolocalization of GLT1c in the mammalian retina and brain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurochem Int (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neuint.2004.04.006"}], "href": "https://doi.org/10.1016/j.neuint.2004.04.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15337309"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15337309"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Noemí García-Tardón, Inmaculada M González-González, Jaime Martínez-Villarreal, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Protein kinase C (PKC)-promoted endocytosis of glutamate transporter GLT-1 requires ubiquitin ligase Nedd4-2-dependent ubiquitination but not phosphorylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M112.355909"}], "href": "https://doi.org/10.1074/jbc.M112.355909"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22505712"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22505712"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Michelle J Chandley, Katalin Szebeni, Attila Szebeni, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Psychiatry Neurosci (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1503/jpn.120110"}], "href": "https://doi.org/10.1503/jpn.120110"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23415275"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23415275"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Qiongman Kong, Kou Takahashi, Delanie Schulte, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased glial glutamate transporter EAAT2 expression reduces epileptogenic processes following pilocarpine-induced status epilepticus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurobiol Dis (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.nbd.2012.03.032"}], "href": "https://doi.org/10.1016/j.nbd.2012.03.032"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22513140"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22513140"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Eiji Kobayashi, Masako Nakano, Kenta Kubota, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Activated forms of astrocytes with higher GLT-1 expression are associated with cognitive normal subjects with Alzheimer pathology in human brain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-018-19442-7"}], "href": "https://doi.org/10.1038/s41598-018-19442-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29374250"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29374250"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Guilian Tian, Qiongman Kong, Liching Lai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurochem (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1471-4159.2010.06661.x"}], "href": "https://doi.org/10.1111/j.1471-4159.2010.06661.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20193040"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20193040"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Marina Bacci, Nicla Lorito, Luigi Ippolito, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2019.06.010"}], "href": "https://doi.org/10.1016/j.celrep.2019.06.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31269432"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31269432"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Myriam Grunewald, David Menaker, Baruch I Kanner "}, {"type": "b", "children": [{"type": "t", "text": "Cysteine-scanning mutagenesis reveals a conformationally sensitive reentrant pore-loop in the glutamate transporter GLT-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M202248200"}], "href": "https://doi.org/10.1074/jbc.M202248200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11994293"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11994293"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Alice Y C Liu, Rohan Mathur, Newton Mei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuroprotective drug riluzole amplifies the heat shock factor 1 (HSF1)- and glutamate transporter 1 (GLT1)-dependent cytoprotective mechanisms for neuronal survival."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.158220"}], "href": "https://doi.org/10.1074/jbc.M110.158220"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21098017"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21098017"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Jiong Tao, Nian Tao Deng, Kalpana Ramnarayanan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CD44-SLC1A2 gene fusions in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Transl Med (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/scitranslmed.3001423"}], "href": "https://doi.org/10.1126/scitranslmed.3001423"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21471434"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21471434"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Eliana S Di Cairano, Alberto M Davalli, Lucia Perego, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The glial glutamate transporter 1 (GLT1) is expressed by pancreatic beta-cells and prevents glutamate-induced beta-cell death."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.183517"}], "href": "https://doi.org/10.1074/jbc.M110.183517"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21335552"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21335552"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Marco Spangaro, Marta Bosia, Andrea Zanoletti, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cognitive dysfunction and glutamate reuptake: effect of EAAT2 polymorphism in schizophrenia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurosci Lett (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neulet.2012.06.030"}], "href": "https://doi.org/10.1016/j.neulet.2012.06.030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22728822"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22728822"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Eva-Maria Gehring, Agathe Zurn, Fabian Klaus, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of the glutamate transporter EAAT2 by PIKfyve."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000257428"}], "href": "https://doi.org/10.1159/000257428"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19910676"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19910676"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Neha Vartak-Sharma, Benjamin B Gelman, Chaitanya Joshi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Astrocyte elevated gene-1 is a novel modulator of HIV-1-associated neuroinflammation via regulation of nuclear factor-κB signaling and excitatory amino acid transporter-2 repression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M114.567644"}], "href": "https://doi.org/10.1074/jbc.M114.567644"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24855648"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24855648"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "S M O'Donovan, K Hasselfeld, D Bauer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Transl Psychiatry (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/tp.2015.74"}], "href": "https://doi.org/10.1038/tp.2015.74"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26057049"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26057049"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Ilaria Guella, Marna B McKenzie, Daniel M Evans, et al. "}, {"type": "b", "children": [{"type": "t", "text": "De Novo Mutations in YWHAG Cause Early-Onset Epilepsy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajhg.2017.07.004"}], "href": "https://doi.org/10.1016/j.ajhg.2017.07.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28777935"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28777935"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Miriam Capri, Fabiola Olivieri, Catia Lanzarini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging Cell (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/acel.12549"}], "href": "https://doi.org/10.1111/acel.12549"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27995756"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27995756"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "A Hoshi, A Tsunoda, T Yamamoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Altered expression of glutamate transporter-1 and water channel protein aquaporin-4 in human temporal cortex with Alzheimer's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropathol Appl Neurobiol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/nan.12475"}], "href": "https://doi.org/10.1111/nan.12475"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29405337"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29405337"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Jürgen Zschocke, Claudia Allritz, Jürgen Engele, et al. "}, {"type": "b", "children": [{"type": "t", "text": "DNA methylation dependent silencing of the human glutamate transporter EAAT2 gene in glial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Glia (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/glia.20497"}], "href": "https://doi.org/10.1002/glia.20497"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17311293"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17311293"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Adriana Medina, Sharon Burke, Robert C Thompson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Glutamate transporters: a key piece in the glutamate puzzle of major depressive disorder."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Psychiatr Res (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jpsychires.2013.04.007"}], "href": "https://doi.org/10.1016/j.jpsychires.2013.04.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23706640"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23706640"}]}, {"type": "r", "ref": 43, "children": [{"type": "t", "text": "E Foran, L Rosenblum, A Bogush, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sumoylation of the astroglial glutamate transporter EAAT2 governs its intracellular compartmentalization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Glia (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/glia.22677"}], "href": "https://doi.org/10.1002/glia.22677"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24753081"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24753081"}]}]}]}
Synonyms EAAT2, GLT-1, HBGT, EIEE41
Proteins EAA2_HUMAN
NCBI Gene ID 6506
API
Download Associations
Predicted Functions View SLC1A2's ARCHS4 Predicted Functions.
Co-expressed Genes View SLC1A2's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View SLC1A2's ARCHS4 Predicted Functions.

Functional Associations

SLC1A2 has 6,920 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 115 datasets.

Click the + buttons to view associations for SLC1A2 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of SLC1A2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles tissues with high or low expression of SLC1A2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of SLC1A2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of SLC1A2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of SLC1A2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
BioGPS Cell Line Gene Expression Profiles cell lines with high or low expression of SLC1A2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of SLC1A2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of SLC1A2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of SLC1A2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of SLC1A2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
CellMarker Gene-Cell Type Associations cell types associated with SLC1A2 gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC1A2 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of SLC1A2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of SLC1A2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of SLC1A2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing SLC1A2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing SLC1A2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with SLC1A2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with SLC1A2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
CORUM Protein Complexes protein complexs containing SLC1A2 protein from the CORUM Protein Complexes dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of SLC1A2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with SLC1A2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
CTD Gene-Chemical Interactions chemicals interacting with SLC1A2 gene/protein from the curated CTD Gene-Chemical Interactions dataset.
CTD Gene-Disease Associations diseases associated with SLC1A2 gene/protein from the curated CTD Gene-Disease Associations dataset.
dbGAP Gene-Trait Associations traits associated with SLC1A2 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by SLC1A2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DISEASES Curated Gene-Disease Association Evidence Scores 2025 diseases involving SLC1A2 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores diseases associated with SLC1A2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with SLC1A2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with SLC1A2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with SLC1A2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with SLC1A2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with SLC1A2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
DrugBank Drug Targets interacting drugs for SLC1A2 protein from the curated DrugBank Drug Targets dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at SLC1A2 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of SLC1A2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of SLC1A2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing SLC1A2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GAD Gene-Disease Associations diseases associated with SLC1A2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GAD High Level Gene-Disease Associations diseases associated with SLC1A2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
GDSC Cell Line Gene Expression Profiles cell lines with high or low expression of SLC1A2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with SLC1A2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing SLC1A2 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of SLC1A2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of SLC1A2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of SLC1A2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of SLC1A2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of SLC1A2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of SLC1A2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GO Biological Process Annotations 2015 biological processes involving SLC1A2 gene from the curated GO Biological Process Annotations 2015 dataset.
GO Biological Process Annotations 2023 biological processes involving SLC1A2 gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving SLC1A2 gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2015 cellular components containing SLC1A2 protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Cellular Component Annotations 2023 cellular components containing SLC1A2 protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Cellular Component Annotations 2025 cellular components containing SLC1A2 protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by SLC1A2 gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by SLC1A2 gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by SLC1A2 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx eQTL 2025 SNPs regulating expression of SLC1A2 gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of SLC1A2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of SLC1A2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of SLC1A2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
Guide to Pharmacology Chemical Ligands of Receptors ligands (chemical) binding SLC1A2 receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset.
GWAS Catalog SNP-Phenotype Associations phenotypes associated with SLC1A2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset.
GWASdb SNP-Disease Associations diseases associated with SLC1A2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.
GWASdb SNP-Phenotype Associations phenotypes associated with SLC1A2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles cell lines with high or low expression of SLC1A2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset.
HMDB Metabolites of Enzymes interacting metabolites for SLC1A2 protein from the curated HMDB Metabolites of Enzymes dataset.
HPA Cell Line Gene Expression Profiles cell lines with high or low expression of SLC1A2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of SLC1A2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of SLC1A2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
HPA Tissue Sample Gene Expression Profiles tissue samples with high or low expression of SLC1A2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset.
Hub Proteins Protein-Protein Interactions interacting hub proteins for SLC1A2 from the curated Hub Proteins Protein-Protein Interactions dataset.
HuBMAP Azimuth Cell Type Annotations cell types associated with SLC1A2 gene from the HuBMAP Azimuth Cell Type Annotations dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with SLC1A2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for SLC1A2 protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of SLC1A2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
KEGG Pathways pathways involving SLC1A2 protein from the KEGG Pathways dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of SLC1A2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of SLC1A2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of SLC1A2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of SLC1A2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of SLC1A2 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
LOCATE Curated Protein Localization Annotations cellular components containing SLC1A2 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain SLC1A2 protein from the LOCATE Predicted Protein Localization Annotations dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by SLC1A2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of SLC1A2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MPO Gene-Phenotype Associations phenotypes of transgenic mice caused by SLC1A2 gene mutations from the MPO Gene-Phenotype Associations dataset.
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations gene perturbations changing expression of SLC1A2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset.
PANTHER Pathways pathways involving SLC1A2 protein from the PANTHER Pathways dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for SLC1A2 from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of SLC1A2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations gene perturbations changing expression of SLC1A2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving SLC1A2 protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving SLC1A2 protein from the Wikipathways PFOCR 2024 dataset.
Phosphosite Textmining Biological Term Annotations biological terms co-occuring with SLC1A2 protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset.
Reactome Pathways 2014 pathways involving SLC1A2 protein from the Reactome Pathways dataset.
Reactome Pathways 2024 pathways involving SLC1A2 protein from the Reactome Pathways 2024 dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of SLC1A2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at SLC1A2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of SLC1A2 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of SLC1A2 gene from the RummaGEO Gene Perturbation Signatures dataset.
SynGO Synaptic Gene Annotations synaptic terms associated with SLC1A2 gene from the SynGO Synaptic Gene Annotations dataset.
Tabula Sapiens Gene-Cell Associations cell types with high or low expression of SLC1A2 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset.
TargetScan Predicted Conserved microRNA Targets microRNAs regulating expression of SLC1A2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of SLC1A2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of SLC1A2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores tissues with high expression of SLC1A2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of SLC1A2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores tissues with high expression of SLC1A2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of SLC1A2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with SLC1A2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with SLC1A2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2014 pathways involving SLC1A2 protein from the Wikipathways Pathways 2014 dataset.
WikiPathways Pathways 2024 pathways involving SLC1A2 protein from the WikiPathways Pathways 2024 dataset.